Extrapulmonary Mycobacteria Tuberculosis Infection in Kidney Graft Recipient: Case Report and Literature Review
Keywords:
Kidney transplantation, Kidney graft recipient, Mycobacteria tuberculosis infection in transplant recipients.Abstract
We present N.K, a 31-year old male from Kenya, East Africa, who is a kidney graft recipient from 2013. He suffered endstage kidney disease from poorly controlled hypertension. Subsequently was transplanted from a living related haploidentical donor. He presented barely two years later with asthenia, general body malaise and back pain. He was diagnosed with an abscess in the transplanted renal bed in the right iliac fossa, which yielded Mycobacteria tuberculosis on polymerase chain reaction, which was rifampicin sensitive. We started him on an anti-TB
References
. Schaaf, S. and A. Zumla, The history of tuberculosis: past, present and challenges for the future, in Tuberculosis: a comprehensive clinical reference, T.M. Daniel, Editor. 2009, Saunders: Philadelphia. p. 1
. Lawn, S.D. and G. Churchyard, Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS, 2009. 4: p. 325-333.
. WHO, Epidemiology, strategy,fi nancing. Global tuberculosis control, 2009.
. Jean, C.Y. and M.B. Murray, Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008. 5: p. e152.
. Dooley, K.E. and R.E. Chaisson, Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis, 2009. 9: p. 737-746.
. Hussein, M.M., J.M. Moij, and H. Roujouleh, Tuberculosis and chronic renal disease. Semin Dial 2003. 16: p. 38-44.
. Kim, H.R., S.S. Hwang, and Y.K. Ro, Solid-organ malignancy as a risk factor for tuberculosis. Respirology, 2008. 13: p. 413-419.
. Silva, F.A., et al., Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica, 2005. 90: p. 1110-1115.
. Brassard, P., A. Kezouh, and S. Suissa, Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 2006. 43: p. 717-722.
. Benito, N., et al., Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect, 2015. 21(7): p. 651-658.
. Singh, N. and D.L. Paterson, Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis, 1998. 27: p. 1266-1277.
. Atasever, A., et al., Tuberculosis in renal transplant recipients on various immunosuppressive regimens. Nephrol Dial Transplant, 2005. 20: p. 797-802.
. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet, 1994. 344: p. 423-428.
. Torre-Cisneros, J., A. Doblas, and J.M. Aguado, Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation)cohort. Clin Infect Dis, 2009. 48: p. 1657-1665.
. Aguado, J.M., J.A. Herrero, and J. Gavalda, Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group,GESITRA. Transplantation, 1997. 63: p. 1278-1286.
. Munoz, P., C. Rodriguez, and E. Bouza, Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis, 2005. 40: p. 581-587.
. Ergun, I., Y. Ekmerkci, and S. Sengul, Mycobacterium tuberculosis infectionin renal transplant recipients. Transplant Proc, 2006. 38: p. 1344-1345.
. Canet, E., et al., Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years. Transplant, 2011. 26: p. 3773-3778.
. Bodro, M., N. Sabe, and M. Santin, Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Transplant Proc 2012. 44: p. 2686-2689.
. Bravo, C., J. Roldan, and A. Roman, Tuberculosis in lung transplant recipients. Transplantation, 2005. 79: p. 59-64.
. Roman, A., C. Bravo, and G. Levy, Isoniazid prophylaxis in lung transplantation. Heart Lung Transplant, 2000. 19: p. 903-906.
. Morales, P., et al., Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain. Transplant Proc, 2005. 37: p. 4050-4055.
. Doblas, A., et al., Tuberculosis in solid organ transplant patients. Enferm Infecc Microbiol Clin, 2012. 30(Suppl 2): p. 34-39.
. Canet, E., et al., Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years. Nephrol Dial Transplant, 2011. 26: p. 3773-3778.
. John, G.T., et al., Risk factors for post-transplant tuberculosis. Kidney Int, 2001. 60(3): p. 1148-1153.
. Boubaker, K., et al., Mycobacterium tuberculosis Infection following Kidney Transplantation. BioMed Research International, 2013. 2013.
. Ramanathan, M., Abdominal tuberculosis: a presumptive diagnosis. Singapore Medical, 1997. 38: p. 364-368.
. Ormerod, L.P., The management of extra-pulmonary tuberculosis. Mycobacteria. 1997, New York: Chapman & Hall.
. Hopewell, P.C., et al., International standards for tuberculosis care. Lancet Infect Dis, 2006. 6: p. 710-725.
. Daugelat, S., et al., The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes Infect, 2003. 5(Suppl 12): p. 1082-1095.
. Mazurek, G.H., et al., Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection
. Schluger, N.W. and J. Burzynski, Recent advances in testing for latent TB. Chest, 2010. 138: p. 1456-1563.
. Herrera, V., et al., Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis, 2011. 52: p. 1031-1037.
. Hadaya, K., P.O. Bridevaux, and P. Roux-Lombard, Contribution of interferon-gamma release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation. Transplantation, 2013. 95: p. 1485-1490.
. Kim, S.Y., G.S. Jung, and S.K. Kim, Comparison of the tuberculin skin test and interferon-gamma release assay for the diagnosis of latent tuberculosis infection before kidney transplantation. Infection, 2013. 41: p. 103-110.
. Kim, S.H., S.O. Lee, and J.B. Park, A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant, 2011. 11: p. 1927-1935.
. Kim, J.S., et al., Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation. Transplant Proc, 2013. 45(8): p. 2899-2902.
. LaboratoryStandardsInstitute, Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes, Approved Standard. 2nd ed. 2011, PA: Wayne.
. Frieden, T., Toman
. Aguado, J.M., J. Torre-Cisneros, and J. Fortun, Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis, 2009. 48: p. 1276-1284.
. Meije, Y., et al., Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect, 2014. 20(7): p. 89-101.
. EBPG, European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infectionsTuberculosis in Nephrol Dial Transplant. 2002. p. 39-43.
. Blumberg, H.M., W.J. Burman, and R.E. Chaisson, American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med, 2003. 167: p. 603-662.
. Buffington, G.A., et al., Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA, 1976. 236: p. 1958-1960.
. Paterson, D.L. and N. Singh, Interactions between tacrolimus and antimicrobial agents. Clin Infect Dis, 1997. 25: p. 1430-1440.
. McAllister, W.A., et al., Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed), 1983. 286: p. 923-925.
. Khan, F.A., J. Minion, and M. Pai, Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis 2010. 50: p. 1288-1299.
. Modry, D.L., et al., Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Transplantation, 1985. 39: p. 313-314.
. Sun, H.Y., P. Munoz, and J. Torre-Cisneros, Mycobacterium Tuberculosis-Associated Immune Reconstitution Syndrome in Solid-Organ Transplant Recipients. Transplantation 2013. 95: p. 1173-1181.
. Cheng, K. and C. Zou, Electromagnetic field effect on separation of nucleotide sequences and unwinding of a double helix during DNA replication. Med Hypotheses, 2006. 66: p. 148-153.
. Chenhsu, R.Y., et al., Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Ann Pharmacother, 2000. 34: p. 27-31.
. Ha, Y.E., E.J. Joo, and S.Y. Park, Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients. Transpl Infect Dis, 2012. 14: p. 626-634.
. Park, Y.S., J.Y. Choi, and C.H. Cho, Clinical outcomes of tuberculosis inrenal transplant recipients. renal transplant recipients, 2004. 45: p. 865-872.
. Chan, A.C., et al., Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation. Liver Int 2007. 27: p. 81-85.
. Al-Sulaiman, M.H., J.M. Dhar, and A.A. Al-Khader, Successful use of rifampicin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine. Transplantation 1990. 50: p. 597-598.
. Lopez-Montes, A., E. Gallego, and E. Lopez, Treatment of tuberculosis with rifabutin in a renal transplant recipient. Am J Kidney Dis, 2004. 44: p. e59-e63.
. Bumbacea, D., et al., The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J, 2012. 40: p. 990-1013.
. Ngo, B.T., M. Pascoe, and D. Khan, Drug interaction between rifampicin and sirolimus in transplant patients. Saudi J Kidney Dis Transpl, 2011. 22: p. 112-115.
. Lefeuvre, S., et al., Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis. Transpl Int, 2012. 25: p. e120-e123.
. Hsu, M.S., J.L. Wang, and W.J. Ko, Clinical features and outcome of tuberculosis in solid organ transplant recipient. Am J Med Sci, 2007. 334: p. 106-110.
. Dromer, C., et al., Tuberculosis in transplanted lungs. J Heart Lung Transplant, 1993. 12: p. 924-927.
. JSaukkonen, J., D.L. Cohn, and R.M. Jasmer, An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med, 2006. 174: p. 935-952.
. Schluger, L.K., P.A. Sheiner, and M. Jonas, Isoniazid hepatotoxicity after orthotopic liver transplantation. Mt Sinai J Med, 1996. 63: p. 364-369.
. Subramanian, A.K. and M.I. Morris, Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant, 2013. 13(Suppl 4): p. 68-76.
. Holty, J.E. and R.r. Sista, Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis. Curr Opin Organ Transplan, 2009. 14: p. 613-618.
. Yehia, B.R. and E.A. Blumberg, Mycobacterium tuberculosis infection in liver transplantation. Liver Transpl, 2010. 16: p. 1129-1135.
. Sakhuja, V., et al., The high incidence of tuberculosis among renal transplant recipients in India. Transplantation, 1996. 61: p. 211-215.
. Ho, C.C., et al., Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens. Clin Infect Dis, 2009. 48: p. 1526-1533.
. Yoon, H.E., Y.J. Jeon, and H.W. Chung, Safety and efficacy of a quinolone-based regimen for treatment of tuberculosis in renal transplant recipients. Transplant Proc, 2012. 44: p. 730-733.
. Jha, V., V. Sakhuja, and D. Gupta, Successful management of pulmonary tuberculosis in renal allograft recipients in a single center. Kidney Int, 1999. 56: p. 1944-1950.
. Jindani, A., M. Hatherill, and S. Charalambous. A multicentre randomized clinical trial to evaluate high-dose Rifapentine with a Quinolone for treatment of pulmonary TB: The RIFAQUIN Trial. 20th Conference on Retroviruses and Opportunistic Infections (CROI). in Abstract. 2013. Atlanta.
. Merle, C., K. Fielding, and O. Lapujade. A randomized controlled trial of 4-month Gatifloxacin-containing regimen vs. standard 6-month regimen for treating drug-susceptible pulmonary tuberculosis: main efficacy and safety results of the FLOTUB Trial. in 44th Union World Conference on Lung Health. 2013. Paris.
. Takiff, H. and E. Guerrero, Current prospects for the fluoroquinolones as first-line tuberculosis therapy. Antimicrob Agents Chemother, 2011. 55: p. 5421-5429.
. Kirsch, S. and M. Sester, Tuberculosis in transplantation. Curr Infect Dis Rep, 2012. 14: p. 650-657.
. Lou, H.X., M.A. Shullo, and T.P. McKaveney, Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population. Pharmacotherapy, 2002. 22: p. 701-704.
. Fortun, J., P. Martin-Davila, and E. Navas, Linezolid for the treatment of multidrug-resistant tuberculosis. J Antimicrob Chemother, 2005. 56: p. 180-185.
. Kliiman, K. and A. Altraja, Predictors of extensively drug-resistant pulmonary tuberculosis. Ann Intern Med, 2009. 150: p. 766-775.
. Migliori, G.B., R. Centis, and L. Fattorini, Mycobacterium tuberculosis complex drug resistance in Italy. Emerg Infect Dis, 2004. 10: p. 752-753.
. Wong, C.F., et al., Lung transplantation in Hong Kong: 12 years of experience. Respirology, 2008. 13: p. 903-907.
. Perri, G.D., R. Luzzati, and A. Forni, Fatal primary multidrug-resistant tuberculosis in a heart transplant recipient. Transpl Int, 1998. 11: p. 305-307.
. Shitrit, D., et al., Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection. Thorax, 2004.
. Chan, E.D., V. Laurel, and M.J. Strand, Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med, 2004. 169: p. 1103-1109.
. Falzon, D., E. Jaramillo, and H.J. Schunemann, WHO guidelines for the programmatic management of drug-resistant tuberculosis. Eur Respir J, 2011. 38: p. 516-528.
. Adamu, B., et al., Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis (Review). The Cochrane Library, 2014(3).
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.
